300 related articles for article (PubMed ID: 11267636)
1. Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice.
Darmani NA
Pharmacol Biochem Behav; 2001 Feb; 68(2):311-7. PubMed ID: 11267636
[TBL] [Abstract][Full Text] [Related]
2. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
Janoyan JJ; Crim JL; Darmani NA
Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
[TBL] [Abstract][Full Text] [Related]
3. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
Darmani NA; Johnson JC
Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
[TBL] [Abstract][Full Text] [Related]
4. Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.
Darmani NA
Neuropsychopharmacology; 2001 Feb; 24(2):198-203. PubMed ID: 11120402
[TBL] [Abstract][Full Text] [Related]
5. Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice.
Darmani NA; Pandya DK
J Neural Transm (Vienna); 2000; 107(8-9):931-45. PubMed ID: 11041273
[TBL] [Abstract][Full Text] [Related]
6. Differential ontogenesis of three DOI-induced behaviors in mice.
Darmani NA; Shaddy J; Gerdes CF
Physiol Behav; 1996 Dec; 60(6):1495-500. PubMed ID: 8946497
[TBL] [Abstract][Full Text] [Related]
7. Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI.
Darmani NA; Gerdes CF
Pharmacol Biochem Behav; 1995 Apr; 50(4):545-50. PubMed ID: 7617700
[TBL] [Abstract][Full Text] [Related]
8. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
Willins DL; Meltzer HY
J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333
[TBL] [Abstract][Full Text] [Related]
9. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen.
Canal CE; Olaghere da Silva UB; Gresch PJ; Watt EE; Sanders-Bush E; Airey DC
Psychopharmacology (Berl); 2010 Apr; 209(2):163-74. PubMed ID: 20165943
[TBL] [Abstract][Full Text] [Related]
10. The head-twitch response in the least shrew (Cryptotis parva) is a 5-HT2- and not a 5-HT1C-mediated phenomenon.
Darmani NA; Mock OB; Towns LC; Gerdes CF
Pharmacol Biochem Behav; 1994 Jun; 48(2):383-96. PubMed ID: 8090805
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development.
De Vry J; Jentzsch KR; Kuhl E; Eckel G
Behav Pharmacol; 2004 Feb; 15(1):1-12. PubMed ID: 15075621
[TBL] [Abstract][Full Text] [Related]
12. Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea.
Parker LA; Mechoulam R; Schlievert C; Abbott L; Fudge ML; Burton P
Psychopharmacology (Berl); 2003 Mar; 166(2):156-62. PubMed ID: 12528012
[TBL] [Abstract][Full Text] [Related]
13. Further evidence for enigmas in adaptation mechanisms for the DOI-induced behaviors.
Darmani NA
Pharmacol Biochem Behav; 1992 Nov; 43(3):765-70. PubMed ID: 1448470
[TBL] [Abstract][Full Text] [Related]
14. Motor-like Tics are Mediated by CB
Gorberg V; Borisov V; Greig IR; Pertwee RG; McCaffery P; Anavi-Goffer S
Mol Neurobiol; 2022 Aug; 59(8):5070-5083. PubMed ID: 35666403
[TBL] [Abstract][Full Text] [Related]
15. Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.
Cheer JF; Cadogan AK; Marsden CA; Fone KC; Kendall DA
Neuropharmacology; 1999 Apr; 38(4):533-41. PubMed ID: 10221757
[TBL] [Abstract][Full Text] [Related]
16. 2,5-Dimethoxy-4-iodoamphetamine (DOI) inhibits Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
Egashira N; Koushi E; Mishima K; Iwasaki K; Oishi R; Fujiwara M
J Pharmacol Sci; 2007 Dec; 105(4):361-6. PubMed ID: 18057774
[TBL] [Abstract][Full Text] [Related]
17. Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover.
Darmani NA; Janoyan JJ; Kumar N; Crim JL
Pharmacol Biochem Behav; 2003 Jul; 75(4):777-87. PubMed ID: 12957219
[TBL] [Abstract][Full Text] [Related]
18. The cannabinoid agonist HU-210: pseudo-irreversible discriminative stimulus effects in rhesus monkeys.
Hruba L; McMahon LR
Eur J Pharmacol; 2014 Mar; 727():35-42. PubMed ID: 24486701
[TBL] [Abstract][Full Text] [Related]
19. Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine.
Lichtman AH; Fisher J; Martin BR
Pharmacol Biochem Behav; 2001; 69(1-2):181-8. PubMed ID: 11420084
[TBL] [Abstract][Full Text] [Related]
20. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats.
Wiley JL; Barrett RL; Lowe J; Balster RL; Martin BR
Neuropharmacology; 1995 Jun; 34(6):669-76. PubMed ID: 7566504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
